What is the typical frequency of flare‑ups (episodes) in working‑age adults with recurrent Major Depressive Disorder and Bipolar I disorder for FMLA documentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Frequency of Flare-Ups in Bipolar I Disorder and Major Depressive Disorder for FMLA Documentation

Direct Answer

For FMLA documentation, expect Bipolar I disorder patients to experience approximately 4 or more mood episodes per year (meeting rapid cycling criteria), while Major Depressive Disorder patients typically experience 2 or more distinct depressive episodes during their illness course, with approximately 50% experiencing relapse within one year of achieving remission. 1, 2, 3


Bipolar I Disorder Episode Frequency

Standard Episode Patterns

  • Rapid cycling is formally defined as four or more mood episodes within one year, which occurs in a substantial subset of Bipolar I patients and represents a clinically recognized pattern requiring documentation. 2

  • Beyond rapid cycling, even more frequent patterns exist: ultrarapid cycling (5-364 cycles per year) and ultradian cycling (more than 365 cycles per year), though these are less common. 2

  • Approximately 75% of symptomatic time in Bipolar I disorder consists of depressive episodes or symptoms, meaning depressive flare-ups dominate the clinical course more than manic episodes. 3

Episode Duration Standards

  • A manic episode must last at least 7 days (or require hospitalization) to meet diagnostic criteria, providing a minimum duration threshold for documenting manic flare-ups. 2, 4

  • Mixed episodes (simultaneous manic and depressive symptoms) also require 7 or more days of concurrent symptoms to qualify as a distinct episode. 2

  • In pediatric and adolescent presentations, episodes may be extremely short-lived, lasting only hours to days, or present as chronic baseline patterns, though this is less applicable to working-age adults. 2

Clinical Course Characteristics

  • Most Bipolar I patients experience major or minor depressive episodes during their lifespan, establishing depression as the predominant source of functional impairment and work absence. 2, 4

  • The illness follows a cyclical nature with distinct episodes in adults, representing significant departures from baseline functioning that are evident across different life domains. 2


Major Depressive Disorder Episode Frequency

Recurrence Patterns

  • Approximately 50% of MDD patients who achieve remission experience relapse during the subsequent year, establishing a baseline annual recurrence rate for documentation purposes. 1

  • Despite fairly high rates of recovery from particular episodes (approximately two-thirds achieve remission within 1 year), depression is highly recurrent, meaning multiple episodes over a working lifetime are the norm rather than the exception. 1

  • For patients who have had 2 or more episodes of depression, longer duration of maintenance therapy is beneficial, implicitly acknowledging that recurrent MDD follows a pattern of multiple discrete episodes. 1

Episode Duration and Treatment Phases

  • The acute phase of treatment targets initial symptom response within 6 to 8 weeks, followed by a continuation phase of 4 to 9 months after satisfactory response for first-episode patients. 1

  • Relapse is defined as the return of depressive symptoms during the acute or continuation phases (within the first year), while recurrence represents a new distinct episode during the maintenance phase (beyond one year). 1

  • This framework suggests that for recurrent MDD, patients are at risk for new episodes annually or more frequently, particularly without adequate maintenance treatment. 1


Key Differences for FMLA Documentation

Bipolar I Disorder

  • Document 4+ episodes per year as a standard expectation for rapid cycling patients, with recognition that many patients cycle even more frequently. 2, 3

  • Each manic episode requires ≥7 days of symptoms or hospitalization, while depressive episodes follow MDD criteria and constitute the majority of symptomatic time. 2, 4, 3

  • Inter-episode mood lability (frequent ups and downs between episodes) occurs in 62.9% of Bipolar II patients and is associated with longer illness duration, suggesting that even between formal episodes, mood instability causes functional impairment. 5

Major Depressive Disorder

  • Document 1-2 episodes per year as a reasonable estimate based on the 50% one-year relapse rate, with higher frequency in patients with recurrent illness. 1

  • Each episode typically requires several weeks to months to achieve remission with treatment, and the continuation phase extends 4-9 months to prevent relapse. 1

  • Recurrent MDD (≥2 lifetime episodes) carries higher risk of future episodes and warrants documentation of chronic recurrent course. 1


Clinical Pitfalls to Avoid

  • Do not assume Bipolar I patients only have manic flare-ups—depressive episodes account for 75% of symptomatic time and are the primary driver of disability. 3

  • Do not underestimate MDD recurrence risk—the 50% one-year relapse rate means half of patients will have another episode within 12 months of remission. 1

  • Recognize that "inter-episode" does not mean asymptomatic—mood lability between formal episodes occurs in the majority of bipolar patients and contributes to functional impairment. 5

  • Avoid documenting only hospitalized episodes—many manic and all hypomanic episodes do not require hospitalization but still cause marked functional impairment requiring work absence. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bipolar Disorder Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Bipolar I Disorder with Manic Aggression and Co‑occurring Nicotine Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.